A Revolution Born from Bacteria

【English】

In 2012, two scientists — Jennifer Doudna and Emmanuelle Charpentier — published a paper that would change the course of medicine forever. They demonstrated that a bacterial immune system called CRISPR-Cas9 could be repurposed as a precise gene-editing tool, capable of cutting DNA at specific locations with unprecedented accuracy. The discovery earned them the Nobel Prize in Chemistry in 2020 and launched a revolution in biotechnology. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, essentially acts as molecular scissors guided by a customizable RNA sequence. Scientists can program it to find a specific gene, cut it, and either disable it or replace it with a corrected version. The implications for treating genetic diseases are profound.

【中文翻译】

2012年，两位科学家——詹妮弗·杜德纳和埃马纽埃尔·卡彭蒂尔——发表了一篇将永远改变医学进程的论文。他们证明，一种名为CRISPR-Cas9的细菌免疫系统可以被改造为精确的基因编辑工具，以前所未有的准确度在特定位置切割DNA。这一发现为她们赢得了2020年诺贝尔化学奖，并引发了生物技术领域的革命。CRISPR（成簇规律间隔短回文重复序列）本质上是一种由可定制RNA序列引导的分子剪刀。科学家可以编程让它找到特定基因、切割它，然后要么使其失活，要么用修正版本替换它。这对治疗遗传疾病的意义深远。

From Laboratory to Hospital Bed

【English】

The first CRISPR-based therapy approved for clinical use arrived in late 2023, when the United Kingdom's MHRA and subsequently the U.S. FDA approved Casgevy (exagamglogene autotemcel) for the treatment of sickle cell disease and transfusion-dependent beta-thalassemia. These inherited blood disorders affect millions of people worldwide, particularly in Africa, the Middle East, and South Asia. Traditional treatments involve lifelong blood transfusions or risky bone marrow transplants. Casgevy works by editing a patient's own bone marrow stem cells to reactivate fetal hemoglobin production, effectively bypassing the defective adult hemoglobin gene. Clinical trials showed that the vast majority of treated patients were freed from painful vaso-occlusive crises and no longer required regular transfusions.

【中文翻译】

首个获批临床使用的CRISPR疗法出现在2023年末，当时英国药品和保健品管理局（MHRA）以及随后的美国食品药品监督管理局（FDA）批准了Casgevy（exagamglogene autotemcel）用于治疗镰状细胞病和输血依赖型β-地中海贫血。这些遗传性血液疾病影响着全球数百万人，尤其是在非洲、中东和南亚。传统治疗包括终身输血或高风险的骨髓移植。Casgevy通过编辑患者自身的骨髓干细胞来重新激活胎儿血红蛋白的产生，有效地绕过了有缺陷的成人血红蛋白基因。临床试验显示，绝大多数接受治疗的患者不再遭受疼痛性血管闭塞危象，也不再需要定期输血。

Beyond Blood Disorders: The Expanding Frontier

【English】

The success with sickle cell disease is only the beginning. Researchers are now exploring CRISPR applications across a wide spectrum of conditions. In oncology, clinical trials are testing CAR-T cells enhanced with CRISPR editing to create more potent cancer-fighting immune cells. Doctors at the University of Pennsylvania have used CRISPR-edited immune cells to treat patients with aggressive cancers, showing promising early results. In the field of infectious disease, researchers are investigating whether CRISPR can target and destroy viral DNA embedded in human cells, offering potential functional cures for HIV and hepatitis B. Vertex Pharmaceuticals and CRISPR Therapeutics continue to expand their pipeline, exploring treatments for type 1 diabetes and Duchenne muscular dystrophy.

【中文翻译】

镰状细胞病的成功只是一个开始。研究人员现在正在探索CRISPR在广泛疾病领域的应用。在肿瘤学方面，临床试验正在测试用CRISPR编辑增强的CAR-T细胞，以创造更强大的抗癌免疫细胞。宾夕法尼亚大学的医生已经使用CRISPR编辑的免疫细胞治疗侵袭性癌症患者，早期结果令人鼓舞。在传染病领域，研究人员正在研究CRISPR能否靶向并摧毁嵌入人体细胞的病毒DNA，为乙型肝炎和HIV提供潜在的功能性治愈。Vertex制药和CRISPR Therapeutics继续扩大其研发管线，探索1型糖尿病和杜氏肌营养不良症的治疗方法。

Ethical Questions We Cannot Ignore

【English】

With great power comes great responsibility, and CRISPR is no exception. The technology raises profound ethical questions that society must grapple with. The most controversial application occurred in 2018, when Chinese scientist He Jiankui announced he had created the world's first gene-edited babies by modifying the CCR5 gene to confer HIV resistance. The global scientific community condemned the experiment as reckless and premature, and He was sentenced to prison. The incident highlighted a critical distinction: editing somatic cells (which affect only the treated individual) is fundamentally different from editing germline cells (which would pass changes to future generations). Most countries have imposed strict regulations on germline editing, but the technology's rapid advancement continues to test the boundaries of existing governance frameworks.

【中文翻译】

能力越大，责任越大，CRISPR也不例外。这项技术引发了社会必须面对的深刻伦理问题。最具争议的应用发生在2018年，当时中国科学家贺建奎宣布，他通过修改CCR5基因来赋予HIV抗性，创造了世界上第一批基因编辑婴儿。全球科学界谴责这一实验草率且不成熟，贺建奎被判入狱。该事件凸显了一个关键区别：编辑体细胞（仅影响被治疗个体）与编辑生殖系细胞（会将改变传递给后代）有本质区别。大多数国家对生殖系编辑实施了严格监管，但技术的快速发展不断考验着现有治理框架的边界。

Democratizing Gene Editing

【English】

One of the most remarkable aspects of CRISPR is its accessibility. Unlike previous gene-editing technologies that required specialized equipment and years of training, CRISPR is relatively simple and inexpensive to use. A basic CRISPR experiment can be conducted for under a hundred dollars, and DIY biology communities have begun experimenting with the technology in community labs. This democratization has accelerated innovation but also raised concerns about biosecurity. As CRISPR kits become available to the public, questions about regulation and oversight grow more urgent. Nevertheless, the open nature of CRISPR research has enabled scientists in developing countries to participate in cutting-edge genetic research, potentially leading to treatments tailored to diseases that disproportionately affect their populations.

【中文翻译】

CRISPR最引人注目的特点之一是其可及性。与需要专业设备和多年培训的以往基因编辑技术不同，CRISPR使用起来相对简单且成本低廉。一次基础的CRISPR实验花费不到一百美元，DIY生物学社区已经开始在社区实验室中试验这项技术。这种民主化加速了创新，但也引发了对生物安全的担忧。随着CRISPR试剂盒向公众开放，有关监管和监督的问题变得更加紧迫。尽管如此，CRISPR研究的开放性使发展中国家的科学家能够参与前沿遗传学研究，可能导致针对不成比例影响其人口的疾病的治疗方法。

【重点词汇】

• repurpose /riːˈpɜːrpəs/ v. 改造，重新利用 — CRISPR was repurposed from a bacterial defense system into a gene-editing tool. （CRISPR从细菌防御系统被改造为基因编辑工具。）
• unprecedented /ʌnˈpresɪdentɪd/ adj. 前所未有的 — The technology offers unprecedented precision in editing DNA. （该技术在编辑DNA方面提供了前所未有的精确度。）
• fetal /ˈfiːtəl/ adj. 胎儿的 — The therapy reactivates fetal hemoglobin production. （该疗法重新激活胎儿血红蛋白的产生。）
• germline /ˈdʒɜːrmˌlaɪn/ n./adj. 生殖系（的） — Germline editing raises concerns about heritable changes. （生殖系编辑引发了关于可遗传改变的担忧。）
• somatic /soʊˈmætɪk/ adj. 体细胞的 — Somatic cell editing affects only the treated individual. （体细胞编辑仅影响被治疗的个体。）
• confer /kənˈfɜːr/ v. 赋予，授予 — The gene modification was intended to confer HIV resistance. （该基因修改旨在赋予HIV抗性。）
• pipeline /ˈpaɪpˌlaɪn/ n. 研发管线 — The company has several CRISPR therapies in its pipeline. （该公司有几种CRISPR疗法在其研发管线中。）
• biosecurity /ˌbaɪoʊsɪˈkjʊrəti/ n. 生物安全 — The democratization of gene editing raises biosecurity concerns. （基因编辑的民主化引发了生物安全担忧。）
• vaso-occlusive /ˌveɪzoʊəˈkluːsɪv/ adj. 血管闭塞的 — Patients were freed from vaso-occlusive crises after treatment. （患者在治疗后摆脱了血管闭塞危象。）
• governance /ˈɡʌvərnəns/ n. 治理，管理 — Existing governance frameworks struggle to keep pace with the technology. （现有治理框架难以跟上技术的步伐。）

【语法要点】

• 同位语解释结构：文中使用括号内插入语解释专业术语，如 "somatic cells (which affect only the treated individual)"，用定语从句充当同位语，帮助读者理解复杂概念。
• 分词短语作后置定语：如 "a paper that would change the course of medicine forever" 中 that 引导的定语从句，以及 "CRISPR-based therapy" 中过去分词短语作前置定语，简洁地传递信息。
• 虚拟语气的隐含使用：如 "whether CRISPR can target and destroy viral DNA" 中 whether 引导的宾语从句表达不确定性，常用于学术写作中讨论未经验证的假设。